Lumida
/ATRC
⌘K
AtriCure Inc

AtriCure Inc

ATRC
$49.28USD↑+0.61%+0.30 today

MARKET CAP

2.5B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$49 – $50

52W RANGE

$25
$50

AI Summary

Stalk
StalkMedium

ATRC remains in a Stage 2 uptrend with a clean, accelerating parabola, but price is deeply overbought and extended above the 9-EMA and 20-EMA. The medium-term bias is bullish; however, execution is deferred. Traders should wait for a consolidation or shallow pullback into the 9-EMA to 20-EMA zone for demand absorption before engaging.

  • ↑2025 revenue $534M (+15% YoY) driven by AtriClip Flex Mini, CryoSphere Max
  • ↑Pain management sales up 28% in 2025 on CryoSphere Max adoption
  • ↓Negative earnings yield and weak profitability metrics signal return challenges
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income